Westhampton Capital, LLC Pfizer Inc Transaction History

Westhampton Capital, LLC

$196 Million
Q3 2024

A detailed history of Westhampton Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Westhampton Capital, LLC holds 41,678 shares of PFE stock, worth $1.14 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

41,678

Previous 31,778 31.15%

Holding current value

$1.14 Million

Previous $889,000 35.66%

% of portfolio

0.62%

Previous 0.49%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$27.7 - $31.39 $274,230 - $310,761	9,900 Added 31.15%	41,678 $1.21 Million
Q2 2024 Jul 19, 2024	BUY	$25.26 - $29.6 $13,261 - $15,540	525 Added 1.68%	31,778 $889,000
Q1 2024 Apr 18, 2024	BUY	$25.89 - $29.73 $132,039 - $151,623	5,100 Added 19.5%	31,253 $867,000
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $7,839 - $10,182	-300 Reduced 1.13%	26,153 $752,000
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $4,813 - $5,626	-150 Reduced 0.56%	26,453 $877,000
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $11,919 - $13,790	-330 Reduced 1.23%	26,603 $975,000
Q1 2023 Apr 14, 2023	BUY	$39.39 - $51.28 $3,939 - $5,128	100 Added 0.37%	26,933 $1.1 Million
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $20,875 - $27,250	500 Added 1.9%	26,833 $0
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $13,959 - $16,551	300 Added 1.15%	26,333 $1.38 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $7,771 - $9,983	-198 Reduced 0.75%	26,033 $1.12 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $8,977 - $10,170	250 Added 0.96%	26,231 $1.03 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $80,376 - $90,648	2,400 Added 10.18%	25,981 $941,000
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $43,511 - $55,328	1,300 Added 5.83%	23,581 $868,000
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $7,143 - $8,381	225 Added 1.02%	22,281 $818,000
Q2 2020 Jul 17, 2020	SELL	$30.12 - $36.54 $12,349 - $14,981	-410 Reduced 1.82%	22,056 $721,000
Q4 2019 Jan 30, 2020	SELL	$32.92 - $37.36 $8,559 - $9,713	-260 Reduced 1.14%	22,466 $880,000
Q3 2019 Oct 16, 2019	SELL	$32.49 - $42.13 $1,299 - $1,685	-40 Reduced 0.18%	22,726 $817,000
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $841,886 - $945,244	22,766 New	22,766 $986,000

Others Institutions Holding PFE

# of Institutions

3,245

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westhampton Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westhampton Capital, LLC with notifications on news.

Account

Westhampton Capital, LLC Pfizer Inc Transaction History